Abstract: |
Although some efforts have been made to direct the antigen specificity of developing T cells by retroviral mediated expression of known TCR, it is not clear if the resultant T cells are fully functional. In this study retroviral gene transfer technology was used to introduce a cDNA encoding the TCR from a known encephalitogenic T cell into the bone marrow of mice. Activated T cells expressing this TCR, which is specific for the Ac1-11 peptide from myelin basic protein presented by I-Au, cause rapid onset of experimental autoimmune encephalomyelitis (EAE). This enabled us to use the onset and progression of the disease as a direct measure of effector functions of T cells generated by this method. The data presented here show that recipients of bone marrow retrovirally transduced with this TCR rapidly develop full-blown EAE that results in paralysis. Therefore, retroviral TCR delivery into the bone marrow supports the development of T cells into fully functional effector cells. © 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. |
Keywords: |
controlled study; protein expression; disease course; nonhuman; methodology; t lymphocyte; t-lymphocytes; myelin basic protein; animal cell; mouse; animals; mice; animal tissue; bone marrow; spleen; animal experiment; animal model; gene transfer; transduction, genetic; t lymphocyte receptor; thymus; receptors, antigen, t-cell; data analysis; retrovirus vector; effector cell; genetic code; t lymphocyte activation; complementary dna; lymphocyte function; retroviridae; paralysis; allergic encephalomyelitis; recipient; tcr; interleukin-4; gene technology; myelin basic proteins; encephalomyelitis, autoimmune, experimental; interferon type ii; gene transfer, horizontal; eac; retroviral gene transfer; t lymphocyte receptor gene
|